How long does GLP-1 prior authorization take?

Standard prior-authorization decisions are made within 24-72 hours. Expedited reviews for urgent clinical situations typically process within 24 hours. Additional documentation requests can extend to 5-7 business days.

Can I appeal a GLP-1 denial?

Yes. Insurer denials can be appealed through internal review and external independent review. Appeals citing the prescribing clinicians rationale and documented BMI/comorbidity history are frequently successful.

Does insurance cover compounded semaglutide?

No. US commercial and government insurance plans do not cover compounded semaglutide. Only FDA-approved versions (Ozempic, Wegovy) are insurance-covered. Compounded GLP-1 is cash-pay only.

What if my employer plan excludes anti-obesity drugs?

Self-funded employer health plans (ERISA plans) can legally exclude anti-obesity drugs even when the state mandates coverage. Options: switch to a spouses plan, use manufacturer Self-Pay programs, or ask HR for a PBM policy review.

Cost & insurance review · Updated July 2026

Does insurance cover GLP-1 drugs?

Medically reviewed by Editorial Medical Review, MD, NAMS-CMP

Quick answer

Yes for most commercial plans, with prior authorization — expect $25-$1,349/month out of pocket depending on coverage. Most commercial insurers cover Wegovy and Zepbound for chronic weight management (BMI ≥30, or ≥27 + comorbidity); Ozempic and Mounjaro are covered for type 2 diabetes. Medicare Part D excludes anti-obesity drugs as of 2026, and Medicaid coverage varies by state.

Price ranges by tier

What each pricing tier includes, sourced from manufacturer pricing pages, Cost Plus Drugs, KFF, LillyDirect, and NovoCare.

Commercial insurance + PA (Wegovy/Zepbound)

$25-$200/mo

Prior authorization required
Manufacturer savings card stackable
Auto-injector pen delivery

Commercial insurance (Ozempic/Mounjaro for T2D)

$25-$100/mo

T2D diagnosis required
Standard formulary tier 2-3

Medicare Part D

$0-$100/mo for T2D only

Covers Ozempic and Mounjaro for T2D
Does NOT cover Wegovy or Zepbound (anti-obesity exclusion)

Cash-pay (self-funded plan exclusion)

$349-$1,349/mo

LillyDirect Self Pay $349-$599/mo (Zepbound)
NovoCare Self Pay $499/mo (Wegovy)
List price $935-$1,349/mo at retail

Factors that affect cost

FDA-approved indication (weight-loss vs T2D)
Plan formulary status and prior-authorization criteria
BMI documentation and comorbidity history
Whether plan is self-funded ERISA (may exclude anti-obesity drugs entirely)
State (Medicaid coverage varies)

Insurance context

Many commercially-insured patients who meet indication criteria can access GLP-1 drugs after navigating prior authorization, though approval is not guaranteed and varies by plan. Medicare statutorily excludes anti-obesity drugs from Part D coverage as of 2026 — a restriction dating to the 2003 Medicare Modernization Act. State Medicaid programs vary widely: states such as CA, MD, MA, MI, NY, and VA cover Wegovy/Zepbound while others such as TX, FL, GA, and NC exclude anti-obesity drugs. Check your specific plan formulary for current coverage.

Financial help options

Manufacturer savings cards: Zepbound ($25/mo), Wegovy ($0-$200/mo), Ozempic ($25/mo) with commercial insurance.
LillyDirect / NovoCare Self Pay ↗: Cash-pay direct programs $349-$599/mo (LillyDirect) and $499/mo (NovoCare).
Prior authorization appeals: Appeals that cite the prescribing clinicians rationale plus documented BMI/comorbidity history are frequently successful.
State insurance commissioner: Can assist when appeals fail or when plans deny coverage against state mandates.

Related brands

Editorial cross-links only — no affiliate CTAs. Follow each link for our full brand review, formulary, and clinician model.

Frequently asked questions

How long does GLP-1 prior authorization take?: Standard prior-authorization decisions are made within 24-72 hours. Expedited reviews for urgent clinical situations typically process within 24 hours. Additional documentation requests can extend to 5-7 business days.
Can I appeal a GLP-1 denial?: Yes. Insurer denials can be appealed through internal review and external independent review. Appeals citing the prescribing clinicians rationale and documented BMI/comorbidity history are frequently successful.
Does insurance cover compounded semaglutide?: No. US commercial and government insurance plans do not cover compounded semaglutide. Only FDA-approved versions (Ozempic, Wegovy) are insurance-covered. Compounded GLP-1 is cash-pay only.
What if my employer plan excludes anti-obesity drugs?: Self-funded employer health plans (ERISA plans) can legally exclude anti-obesity drugs even when the state mandates coverage. Options: switch to a spouses plan, use manufacturer Self-Pay programs, or ask HR for a PBM policy review.

Sources

Every pricing figure is sourced from public manufacturer pages, Cost Plus Drugs, KFF, or FDA data. External links open in a new tab.